PUBLICACIONES RECIENTES (2022-2023):
Arjona-Sanchez A. et al. Intraoperative hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomised, controlled, phase 3 trial. JAMA Surg 2023. Published online April 26, 2023. doi:10.1001/jamasurg.2023.0662
Duran-Martinez M., Arjona-Sanchez A. Learning Curve for Minimal Invasive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Procedures. Langenbeck’s archives of Surgery. 2023 in press.
Arjona-Sánchez A, Martínez-López A, Moreno-Montilla MT, Mulsow J, Lozano-Lominchar P, Martínez-Torres B, Rau B, Canbay E, Sommariva A, Milione M, Deraco M, Sgarbura O, Torgunrud A, Kapenekian V, Carr NJ, Hoorens A, Delhorme JB, Wernert R, Goere D, Martin-Roman L, Cosyns S, Flatmark K, Davidson B, Khellaf L, Pereira-Perez F, Rodríguez-Ortiz L, Ibáñez-Costa A, Romero-Ruiz A; EuroPMP COST action and GECOP group (Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Ortega-Salas R, Granados-Rodríguez M, Vázquez-Borrego MC, Bura FI, Castaño JP, Kusamura S, Baratti D, Guaglio M, Castaño PAA, Ruiz de Valbuena Bueno C, Quénet F, Yilmaz S, Canbay TB, Sola Vendrell E, González-Bayón L, Ceelen W, Willaert W, Demuytere J, Alberto-Vilchez ME, Gül-Klein S, Glehen O, Bonnefoy I, Odin C, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Bertheau P, Kassem M, Sourrouille I, Gelli M, Honore C, Dartigues P, Boige V, Verriele V, Brignad C, Averous G, Shields C, Aird J, Scapinello A, Biatta MC, Tonello M, Cenzi C. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification. Eur J Surg Oncol. 2023. DOI: 10.1016/j.ejso.2023.03.206.
Rubio-López JD, Durán-Martínez M, Moreno-Blázquez A, Rodríguez-Ortiz L, Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez A. Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbecks Arck Surg. 2023. DOI: 10.1007/s00423-023-02770-2.
Valenzuela-Molina F, Bura FI, Vázquez-Borrego MC, Granados-Rodríguez M, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Ortega-Salas R, Martínez-López A, Michán C, Alhama J, Arjona-Sánchez A, Romero-Ruiz A. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series. Front Oncol. 2023. DOI: 10.3389/fonc.2023.1076500.
Zwanenburg ES, Gehrels AM, Bastiaenen VP, Aalbers AGJ, Arjona-Sánchez A, Bellato V, van der Bilt JDW, D´Hoore ADD, Espinosa-Redondo E, Klaver CEL, Kusters M, Nagtegaal ID, van Ramshorst B, van Santvoort HC, Sica GS, Snaebjornsson P, Wasmann KATGM, de Wilt JHW, Wolthuis AM, Tanis PJ. Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion. Eur J Surg Oncol. 2022. DOI: 10.1016/j.ejso.2022.05.028.
Casado-Adam A, Rodríguez-Ortiz L, Rufián-Peña S, Muñoz-Casares C, Caro-Cuenca T, Ortega-Salas R, Fernández-Peralbo MA, Luque-de-Castro MD, Sánchez-Hidalgo JM, Hervás-Martínez C, Romero-Ruiz A, Briceño J, Arjona-Sánchez A. The role of intraperitoneal intraoperative chemotherapy with paclitaxel in the surgical treatment of peritoneal carcinomatosis from ovarian cancer-hyperthermica versus normothermia: A randomized controlled trial. J Clin Med. 2022. DOI: 10.3390/jcm11195785.
Durán-Martínez M, Calleja-Lozano R, Arjona-Sánchez A, Sánchez-Hidalgo JM, Ayllón-Terán MD, Rodríguez-Ortiz L, Campos-Hernández P, Rodríguez-Benot A, Briceño-Delgado J. Short- and Long-term intestinal complications after combined pancreas-kidney transplantation. Transplant Proc. 2022. DOI: 10.1016/j.transproceed.2022.09.014.
Rufián-Andujar B, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez A, Rufián-Peña S, Briceño-Delgado FJ. Robotic right hemicolectomy for ileal neuroendocrine tumour. Colorectal Dis. 2022. DOI: 10.1111/codi.16138.
Pérez-de-Villar JM, Arjona-Sánchez A, Rufián-Andujar B, Valenzuela-Molina F, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Casado-Adam A, Viyuela-García C, Rufián-Peña S, Caro-Cuenca T, Moreno-Vega A, Briceño-Delgado J. Surgical treatment of vena cava leiomyosarcomas: Series of cases in a referral center and literatura review. Cir Esp (Engl Ed). 2022. DOI: 10.1016/j.cireng.2022.05.020.
Perdices-López C, Avendaño MS, Barroso A, Gaytán F, Ruiz-Pino F, Vázquez MJ, León S, Bhum Song Y, Sobrino V, Heras V, Romero-Ruiz A, Roa J, Mayor JR F, Murga C, Pinilla L, Kaiser UB, Tena-Sempere M. Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated represión of kisspeptin actions in GnRH neurons. Metabolism. 2022. DOI: 10.1016/j.metabol.2022.155141.
Pereira F, Serrano A, Manzanedo I, Pérez-Viejo E, González-Moreno S, González-Bayón L, Arjona-Sánchez A, Torres J, Ramos I, Barrios ME, Cascales P, Morales R, Boldó E, García-Fadrique A, Artega X, Gutierrez-Calvo A, Sánchez-García S, Asensio E, Ramírez CP, Artiles M, Vaqué J, Parra PA, Villarejo P, Muñoz-Casares C, Turienzo E, Calero A, Jaén-Torrejimeno I, Prieto I, Galindo J, Borrego V, Marcello ME, Rihuete C, Carrasco J, Gómez-Quiles L. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherape (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. BMC Cancer. 2022. DOI: 10.1186/s12885-022-09572-7.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rodríguez-Ortiz L, Granados-Rodríguez M, Romero-Ruiz A. ASO Author Reflections: Towards a Precision Medicine in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10435-x.
Pedraza-Arevalo S, Ibáñez-Costa A, Blázquez-Encinas R, Branco MR, Vázquez-Borrego MC, Herrera-Martínez AD, Venegas-Moreno E, Serrano-Blanch R, Arjona-Sánchez A, Gálvez-Moreno MA, Korbonits M, Soto-Moreno A, Gahete MD, Charalambous M, Luque RM, Castaño JP. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors. Mol Oncol. 2022. DOI: 10.1002/1878-0261.13107.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Medina-Fernández FJ, Díaz-López C, Granados-Rodriguez M, Ortega-Salas R, Castaño JP, Tena-Sempere M, Briceño-Delgado J, Romero-Ruiz A. A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10372-9.
Publicaciones 2023
Arjona-Sanchez A. et al. Intraoperative hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomised, controlled, phase 3 trial. JAMA Surg 2023. Published online April 26, 2023. doi:10.1001/jamasurg.2023.0662
Duran-Martinez M., Arjona-Sanchez A. Learning Curve for Minimal Invasive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Procedures. Langenbeck’s archives of Surgery. 2023 in press.
Arjona-Sánchez A, Martínez-López A, Moreno-Montilla MT, Mulsow J, Lozano-Lominchar P, Martínez-Torres B, Rau B, Canbay E, Sommariva A, Milione M, Deraco M, Sgarbura O, Torgunrud A, Kapenekian V, Carr NJ, Hoorens A, Delhorme JB, Wernert R, Goere D, Martin-Roman L, Cosyns S, Flatmark K, Davidson B, Khellaf L, Pereira-Perez F, Rodríguez-Ortiz L, Ibáñez-Costa A, Romero-Ruiz A; EuroPMP COST action and GECOP group (Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Ortega-Salas R, Granados-Rodríguez M, Vázquez-Borrego MC, Bura FI, Castaño JP, Kusamura S, Baratti D, Guaglio M, Castaño PAA, Ruiz de Valbuena Bueno C, Quénet F, Yilmaz S, Canbay TB, Sola Vendrell E, González-Bayón L, Ceelen W, Willaert W, Demuytere J, Alberto-Vilchez ME, Gül-Klein S, Glehen O, Bonnefoy I, Odin C, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Bertheau P, Kassem M, Sourrouille I, Gelli M, Honore C, Dartigues P, Boige V, Verriele V, Brignad C, Averous G, Shields C, Aird J, Scapinello A, Biatta MC, Tonello M, Cenzi C. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification. Eur J Surg Oncol. 2023. DOI: 10.1016/j.ejso.2023.03.206.
Rubio-López JD, Durán-Martínez M, Moreno-Blázquez A, Rodríguez-Ortiz L, Rufián-Andújar B, Valenzuela-Molina F, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez A. Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbecks Arck Surg. 2023. DOI: 10.1007/s00423-023-02770-2.
Valenzuela-Molina F, Bura FI, Vázquez-Borrego MC, Granados-Rodríguez M, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Ortega-Salas R, Martínez-López A, Michán C, Alhama J, Arjona-Sánchez A, Romero-Ruiz A. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series. Front Oncol. 2023. DOI: 10.3389/fonc.2023.1076500.
Publicaciones 2022
Zwanenburg ES, Gehrels AM, Bastiaenen VP, Aalbers AGJ, Arjona-Sánchez A, Bellato V, van der Bilt JDW, D´Hoore ADD, Espinosa-Redondo E, Klaver CEL, Kusters M, Nagtegaal ID, van Ramshorst B, van Santvoort HC, Sica GS, Snaebjornsson P, Wasmann KATGM, de Wilt JHW, Wolthuis AM, Tanis PJ. Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion. Eur J Surg Oncol. 2022. DOI: 10.1016/j.ejso.2022.05.028.
Casado-Adam A, Rodríguez-Ortiz L, Rufián-Peña S, Muñoz-Casares C, Caro-Cuenca T, Ortega-Salas R, Fernández-Peralbo MA, Luque-de-Castro MD, Sánchez-Hidalgo JM, Hervás-Martínez C, Romero-Ruiz A, Briceño J, Arjona-Sánchez A. The role of intraperitoneal intraoperative chemotherapy with paclitaxel in the surgical treatment of peritoneal carcinomatosis from ovarian cancer-hyperthermica versus normothermia: A randomized controlled trial. J Clin Med. 2022. DOI: 10.3390/jcm11195785.
Durán-Martínez M, Calleja-Lozano R, Arjona-Sánchez A, Sánchez-Hidalgo JM, Ayllón-Terán MD, Rodríguez-Ortiz L, Campos-Hernández P, Rodríguez-Benot A, Briceño-Delgado J. Short- and Long-term intestinal complications after combined pancreas-kidney transplantation. Transplant Proc. 2022. DOI: 10.1016/j.transproceed.2022.09.014.
Rufián-Andujar B, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez A, Rufián-Peña S, Briceño-Delgado FJ. Robotic right hemicolectomy for ileal neuroendocrine tumour. Colorectal Dis. 2022. DOI: 10.1111/codi.16138.
Pérez-de-Villar JM, Arjona-Sánchez A, Rufián-Andujar B, Valenzuela-Molina F, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Casado-Adam A, Viyuela-García C, Rufián-Peña S, Caro-Cuenca T, Moreno-Vega A, Briceño-Delgado J. Surgical treatment of vena cava leiomyosarcomas: Series of cases in a referral center and literatura review. Cir Esp (Engl Ed). 2022. DOI: 10.1016/j.cireng.2022.05.020.
Perdices-López C, Avendaño MS, Barroso A, Gaytán F, Ruiz-Pino F, Vázquez MJ, León S, Bhum Song Y, Sobrino V, Heras V, Romero-Ruiz A, Roa J, Mayor JR F, Murga C, Pinilla L, Kaiser UB, Tena-Sempere M. Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated represión of kisspeptin actions in GnRH neurons. Metabolism. 2022. DOI: 10.1016/j.metabol.2022.155141.
Pereira F, Serrano A, Manzanedo I, Pérez-Viejo E, González-Moreno S, González-Bayón L, Arjona-Sánchez A, Torres J, Ramos I, Barrios ME, Cascales P, Morales R, Boldó E, García-Fadrique A, Artega X, Gutierrez-Calvo A, Sánchez-García S, Asensio E, Ramírez CP, Artiles M, Vaqué J, Parra PA, Villarejo P, Muñoz-Casares C, Turienzo E, Calero A, Jaén-Torrejimeno I, Prieto I, Galindo J, Borrego V, Marcello ME, Rihuete C, Carrasco J, Gómez-Quiles L. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherape (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. BMC Cancer. 2022. DOI: 10.1186/s12885-022-09572-7.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rodríguez-Ortiz L, Granados-Rodríguez M, Romero-Ruiz A. ASO Author Reflections: Towards a Precision Medicine in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10435-x.
Pedraza-Arevalo S, Ibáñez-Costa A, Blázquez-Encinas R, Branco MR, Vázquez-Borrego MC, Herrera-Martínez AD, Venegas-Moreno E, Serrano-Blanch R, Arjona-Sánchez A, Gálvez-Moreno MA, Korbonits M, Soto-Moreno A, Gahete MD, Charalambous M, Luque RM, Castaño JP. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors. Mol Oncol. 2022. DOI: 10.1002/1878-0261.13107.
Arjona-Sánchez A, Martínez-López A, Valenzuela-Molina F, Rufián-Andujar B, Rufián-Peña S, Casado-Adam A, Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Medina-Fernández FJ, Díaz-López C, Granados-Rodriguez M, Ortega-Salas R, Castaño JP, Tena-Sempere M, Briceño-Delgado J, Romero-Ruiz A. A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei. Ann Surg Oncol. 2022. DOI: 10.1245/s10434-021-10372-9.
Publicaciones 2021
Rufian-Andujar B, Valenzuela-Molina F, Rufian-Pena S, Casado-Adam A, Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Medina-Fernandez FJ, Diaz-Lopez C, Ortega-Salas R, Martinez-Lopez A, Briceno-Delgado J, Romero-Ruiz A, Arjona-Sanchez A. From the Ronnett to the PSOGI Classification System for Pseudomyxoma Peritonei: A Validation Study. ANNALS OF SURGICAL ONCOLOGY. 202 28(5):2819-2827. DOI: 10.1245/s10434-020-09560-w. IF: 5,344 Q1 D1
Rodriguez-Ortiz L, Arjona-Sanchez A, Ibanez-Rubio M, Sanchez-Hidalgo J, Casado-Adam A, Rufian-Pena S, Briceno-Delgado J. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2021. 35(4):1778-1785. DOI: 10.1007/s00464-020-07572-x.
IF: 4,584 Q1 D2
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Esquivel J, Van der Speeten K, Piso P, Nedelcut DS, Sommariva A, Yonemura Y, Turaga K, Selvasekar CR, Rodriguez-Ortiz L, Sanchez-Hidalgo JM, Casado-Adam A, Rufian-Pena S, Briceno J, Glehen O. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry. EJSO. 2021. 47(6):1420-1426. DOI: 10.1016/j.ejso.2020.11.140.
IF: 4,424 Q1 D2
Romero-Ruiz A, Pineda B, Ovelleiro D, Perdices-Lopez C, Torres E, Vazquez MJ, Guler I, Jimenez A, Pineda R, Persano M, Romero-Baldonado C, Arjona JE, Lorente J, Munoz C, Paz E, Garcia-Maceira FI, Arjona-Sanchez A, Tena-Sempere M. Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021. 185(5):637-652. DOI: 10.1530/EJE-21-0552.
IF: 6,664 Q1 D2
Rebollo-Roman A, Alhambra-Exposito MR, Herrera-Martinez Y, Leiva-Cepas F, Alzas C, Munoz-Jimenez C, Ortega-Salas R, Molina-Puertas MJ, Galvez-Moreno MA, Herrera-Martinez AD. Catecholaminergic Crisis After a Bleeding Complication of COVID-19 Infection: A Case Report. FRONTIERS IN ENDOCRINOLOGY. 202 12():-. DOI: 10.3389/fendo.202693004.
IF: 5,555 Q1 D3
Alors-Perez E, Blazquez-Encinas R, Alcala S, Viyuela-Garcia C, Pedraza-Arevalo S, Herrero-Aguayo V, Jimenez-Vacas JM, Mafficini A, Sanchez-Frias ME, Cano MT, Abollo-Jimenez F, Marin-Sanz JA, Cabezas-Sainz P, Lawlor RT, Luchini C, Sanchez L, Sanchez-Hidalgo JM, Ventura S, Martin-Hijano L, Gahete MD, Scarpa A, Arjona-Sanchez A, Ibanez-Costa A, Sainz B, Luque RM, Castano JP. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2021. 40(1):-. DOI: 10.1186/s13046-021-02153-9.
IF: 11,161 Q1 D1
Gonzalez-Borja I, Alors-Perez E, Amat I, Alonso L, Viyuela-Garcia C, Goni S, Reyes JC, Ceballos-Chavez M, Hernandez-Garcia I, Sanchez-Frias ME, Santamaria E, Razquin S, Arjona-Sanchez A, Arrazubi V, Perez-Sanz J, Vera R, Fernandez-Irigoyen J, Castano JP, Viudez A. Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. FRONTIERS IN MEDICINE. 2021. 8():-. DOI: 10.3389/fmed.2021.720128.
IF: 5,093 Q1 D2
4.- Bastiaenen VP, Aalbers AGJ, Arjona-Sánchez A, Bellato V, van der Bilt JDW, D'Hoore AD, Espinosa-Redondo E, Klaver CEL, Nagtegaal ID, van Ramshorst B, van Santvoort HC, Sica GS, Snaebjornsson P, Wasmann KATGM, de Wilt JHW, Wolthuis AM, Tanis PJ. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study. Eur J Surg Oncol. 2021 Sep;47(9):2405-2413. doi: 10.1016/j.ejso.2021.05.009. Q1 D2
Publicaciones 2020
Guil-Luna S, Mena R, Navarrete-Sirvent C, Lopez-Sanchez LM, Khouadri K, Toledano-Fonseca M, Mantrana A, Guler I, Villar C, Diaz C, Medina-Fernandez FJ, De la Haba-Rodriguez JR, Aranda E, Rodriguez-Ariza A,. Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts. FRONTIERS IN MEDICINE. 2020. 7 ():- DOI: 10.3389/fmed.2020.00264
IF: 3,9 Q: 1
Lozano RC, Fernandez FJM, Lopez CAD, Tordera EMT, Valiente JC, Delgado FJB. A combined robotic approach to a synchronous upper rectal and prostate cancer - a video vignette. COLORECTAL DISEASE. 2020. 22 (12):2338-2339 DOI: 10.1111/codi.15274
IF: 2,769 Q: 2
Cascales-Campos PA, Lopez-Lopez V, Torres-Melero J, Arjona A, Munoz-Casares FC, Barrios P, Morales R, Pereira F, Bretcha-Boix P, Gonzalez-Bayon L, Gonzalez-Moreno S, Gil J. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP). CLINICAL & TRANSLATIONAL ONCOLOGY. 2020. 22 (1):130-136 DOI: 10.1007/s12094-019-02124-9
IF: 2,737 Q: 3
Arjona-Sanchez A, Cortes-Guiral D, Duran-Martinez M, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Rodriguez-Ortiz L, Romero-Ruiz A, Rufian-Andujar B, Espinosa-Redondo E, Valenzuela-Molina F, Rufian-Pena S, Briceno-Delgado J. Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy. TECHNIQUES IN COLOPROCTOLOGY. 2020. 24 (10):1083-1088 DOI: 10.1007/s10151-020-02277-8
IF: 2,721 Q: 2
Arjona-Sanchez A. Hyperthermic intraperitoneal chemotherapy as adjuvant therapy in locally advanced colon cancer. TECHNIQUES IN COLOPROCTOLOGY. 2021. 25 (1):147-148 DOI: 10.1007/s10151-020-02304-8
IF: 2,721 Q: 2
Navarro-Barrios A, Gil-Martinez J, Ramos-Bernardo I, Barrios P, Munoz-Casares C, Torres-Melero J, Pereira F, Manzanedo I, Arjona A, Martinez-Regueira F, Cascales-Campos PA. Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?. SURGICAL ONCOLOGY-OXFORD. 2020. 33 ():19-23 DOI: 10.1016/j.suronc.2019.12.002
IF: 2,521 Q: 2
Garcia CV, Fernandez FJM, Arjona-Sanchez A, Casado-Adam A, Hidalgo JMS, Pena SR, Delgado JB. Systemic inflammatory markers for the detection of infectious complications and safe discharge after cytoreductive surgery and HIPEC. SURGICAL ONCOLOGY-OXFORD. 2020. 34 ():163-167 DOI: 10.1016/j.suronc.2020.04.013
IF: 2,521 Q: 2
Segura-Sampedro JJ, Morales-Soriano R, Arjona-Sanchez A, Cascales-Campos P. Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease. WORLD JOURNAL OF SURGICAL ONCOLOGY. 2020. 18 (1):- DOI: 10.1186/s12957-020-01853-4
IF: 1,963 Q: 2
Publicaciones 2019
Arjona-Sanchez A, Rodriguez-Ortiz L, Baratti D, Schneider MA, Gutiérrez-Calvo A, García-Fadrique A, Tuynman JB, Cascales-Campos PA, Martín VC, Morales R, Salti GI, Arteaga X, Pacheco D, Alonso-Gomez J, Yalkin O, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Rufian-Peña S, Briceño J. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score. Ann Surg Oncol. 2019 Aug;26(8):2595-2604. PMID 31111351
IF: 3.857 D: 1
Sánchez-Hidalgo JM, Rodríguez-Ortiz J, Arjona-Sánchez Á, Rufián-Peña S, Casado-Adam Á, Cosano-Álvarez A, Briceño-Delgado J. Colorectal Peritoneal Metastases: Optimal Management Review. World J Gastroenterol. 2019 Jul 21;25(27):3484-3502. PMID: 31367152
IF: 3.411 Q: 2
Arjona-Sanchez A, Esquivel J, Glehen O, Passot G, Turaga KK, Labow D, Rufian-Peña S, Morales R, van der Speeten K. A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc. 2019 Mar;33(3):854-860. PMID 30003349
IF: 2.374 Q: 1
Arjona-Sanchez Á, Rodriguez Ortiz L. ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC. Ann Surg Oncol. 2019 Aug;26-8, pp.2605-2606. PMID: 31004296
IF: 3.681 Q: 1
Arjona-Sánchez Á, Durán M, Sánchez-Hidalgo JM, Rufian-Peña S. Peritoneal Carcinomatosis From Ovarian Carcinoma Treated by Interval Laparoscopic Complete Cytoreduction and HIPEC With Extraction Through Natural Orifice. Surg Oncol. 2019 Dec;31:14-15. PMID: 31472328
IF: 3.0 Q: 1
Romero-Ruiz A, Avendaño MS, Dominguez F, Lozoya T, Molina-Abril H, Sangiao-Alvarellos S, Gurrea M, Lara-Chica M, Fernandez-Sanchez M, Torres E, Perdices-López C, Abbara A, Steffani L, Calzado MA, Dhillo WS, Pellicer A,Tena-Sempere M. Deregulation of miR-324/Kiss1/kisspeptin in early ectopic pregnancy: Mechanistic findings with clinical and diagnostic implication. American Journal of Obstetrics and Gynecology. 2019. Vol 220 (5), pp. 480e1 - 480e17. PMID: 30707968
IF: 6.1 D: 1
Romero-Ruiz A, Skorupskaite K, Gaytan F, Torres-Jimenez E, Perdices-Lopez C, Mannaerts BM, Qi S, Leon S, Manfredi-Lozano M, Lopez-Rodriguez C, Avendaño MS, Sanchez-Garrido MA, Vazquez MJ, Pinilla L, van Duin M, Kohout T, Anderson RA, Tena-Sempere, M. Kisspeptin Treatment Induces Gonadotropic Responses and Rescues Ovulation in Preclinical Models & Women with Polycystic Ovary Syndrome. Human Reproduction. 2019 Dec 1;34(12):2495-2512. PMID: 31820802
IF: 5.5 D: 1
Manzanedo I, Pereira F, Rihuete Caro C, Pérez-Viejo E, Serrano Á, Gutiérrez Calvo A, Regueira FM, Casado-Adam Á, Cascales-Campos PA, Arteaga X, García-Fadrique A, Gómez Sanz R, López García A, Zozaya G, Arjona Á, Gil Martínez J. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer With Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol. 2019 Aug;26(8):2615-2621. PMID: 31115852
IF: 3.681 Q: 1
Velasco I, León S, Barroso A, Ruiz-Pino F, Heras V, Torres E, León M, Ruohonen ST, García-Galiano D, Romero-Ruiz A, Sánchez-Garrido MA, Olhsson C, Castellano JM, Roa J, Poutanen M, Pinilla L, Vázquez MJ, Tena-Sempere M. Gonadal Hormone-Dependent vs. -Independent Effects of Kisspeptin Signaling in the Control of Body Weight and Metabolic Homeostasis. Metabolism. Jun 18. pii: S0026-0495(19)30116-7. 2019. ISSN 0026-0495. PMID: 31226351
IF: 6.5 D:1
